Ence Chuck bought RLMD
December 12, 2025 · Form 4 insider transaction
Ence Chuck bought 828,000 shares of Relmada Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
828,000
Price
$0.00
Total value
N/A
InsiderEnce Chuck
Role—
SecurityStock Appreciation Rights
Transaction codeA: Grant or award
Transaction dateDecember 12, 2025
Filing dateDecember 16, 2025
Shares owned after828,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock appreciation rights vest in 16 equal quarterly installments commencing on March 12, 2026.